| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6005786 | Brain Stimulation | 2016 | 7 Pages |
Abstract
Maintaining treatment-resistant depressed patients off medications with periodic TMS appears feasible in some cases. There was no statistical advantage of SCH vs. OBS, although SCH was associated with a nonsignificantly longer time to relapse. Those who initially respond to TMS have a strong chance of re-responding if relapse occurs.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Noah S. Philip, David L. Dunner, Sheila M. Dowd, Scott T. Aaronson, David G. Brock, Linda L. Carpenter, Mark A. Demitrack, Sarit Hovav, Philip G. Janicak, Mark S. George,